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Fact 1: Infection with Giardia lamblia is one of the most common
causes of waterborne nonbacterial and nonviral diarrheal disease
G. lamblia (syn. intestinalis, duodenalis) is a zoonotic enteroparasite. It proliferates in an extra-
cellular and noninvasive fashion in the small intestine of vertebrate hosts, causing the diarrheal
disease known as giardiasis. Virtually all mammals can be infected with G. lamblia, and epide-
miological data point to giardiasis as a zoonosis [1]. Infections in humans may be asymptom-
atic or associated with diarrhea, malabsorption, bloating, abdominal pain, fatigue, and weight
loss. Based on the latest figures provided by WHO, G. lamblia is the third most common agent
of diarrheal disease worldwide with over 300 million reported cases per annum, preceded only
by rotavirus and Cryptosporidium parvum and hominis in the most vulnerable target group of
children under five years of age [2]. The prevalence of giardiasis in humans ranges from 2%–
3% in industrialized countries, up to 30% in low-income and developing countries [3]. Giardi-
asis was formerly included in the WHO neglected diseases initiative and is directly associated
with poverty and poor quality of drinking water [4]. Acute infection develops over a period of
three weeks, peaking at eight days post infection. Generally, healthy hosts clear the infection
within 2–3 weeks, whereas the occasional chronically infected host shows signs of villus and
crypt atrophy, enterocyte apoptosis, and ultimately severe disruption of epithelial barrier func-
tion [5]. Infection with G. lamblia has also been linked to the development of irritable bowel
syndrome and chronic fatigue [6].
Fact 2: G. lamblia presents a simplified subcellular organization
but is not a primitive eukaryote
To date, four types of endomembrane compartments have been identified in the Giardia tro-
phozoite, namely: the endoplasmic reticulum (ER), the nuclei, terminally-differentiated mito-
chondrial remnants named mitosomes, and peripheral vacuoles (PVs) [7]. Encystation-
specific vesicles (ESVs) constitute a fifth compartment present only in encysting cells. Extreme
genomic divergence has led to frequent artefacts such as long-branch attraction in earlier phy-
logenetic studies [8]. Combined with observations of elements of prokaryotic metabolism and
the absence of bona fide eukaryotic organelles such as the Golgi apparatus, endosomes, and
mitochondria, this resulted in a misclassification of G. lamblia as a primitive eukaryote and a
concomitant misinterpretation of its evolutionary history [9]. However, molecular paleontol-
ogy approaches aimed at identifying machinery present in the last eukaryotic common ances-
tor (LECA) indicated that this organism likely possessed all extant eukaryotic organelles and
corresponding trafficking pathways. This supports the notion that species with a simplified cel-
lular organization such as the ancestor of G. lamblia evolved via a reduction of complexity,
likely linked to adoption of a parasitic lifestyle, and that G. lamblia is therefore most likely not
a primary primitive eukaryote but secondarily reduced. Interestingly, recent efforts aimed at
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rooting the eukaryotic tree place this root between the Excavata supergroup, to which G. lam-
blia belongs, and all other eukaryotes [10].
Fact 3: G. lamblia feeds using specialized organelles called PVs
Due to streamlining of most anabolic pathways, G. lamblia cells are highly dependent on nutri-
ent uptake from the host’s gut by means of an array of organelles, i.e., PVs (Fig 1A). This active
host–pathogen interface is at the crossroads of both endo- and exocytic trafficking in G. lam-
blia trophozoites (Fig 1B). The main function of PVs is to periodically endocytose fluid-phase
extracellular material and to expel harmful or unusable substances into the environment
again. This is in contrast to the unidirectional endocytic uptake of fluid-phase material via
cytostome-like structures in many protozoa as well as in Spironucleus spp., the closest known
relatives of Giardia [11]. PVs effectively act as “safety-lock" compartments for efficient envi-
ronmental sampling, i.e., the uptake and intracellular sorting of gut content. The “kiss and
flush” working model (Fig 1C) developed in our group is based on experimental data suggest-
ing that PV membranes and the plasma membrane (PM) transiently fuse (the “kiss” phase)
and become continuous, thereby generating an opening to the extracellular space allowing
exchange of fluid-phase material between the PV lumen and the environment [12]. This PV–
PM connection is then resolved, and sorting of usable nutrients occurs within the acidifying
PV lumen. Any material that is not retained would then be released back into the extracellular
space in a new round of PV–PM connection (the “flush” phase). The flushing of the PV lumen
Fig 1. A working model for fluid-phase and receptor-mediated nutrient uptake through the PVs of G. lamblia. (A) A TEM image of a PV
making contact with a PM-derived invagination (white star). (B) Connections between PVs and ER membranes (white star) are frequently detected
in TEM tomograms. (C) The “kiss and flush” working model for fluid-phase and receptor-mediated endocytosis in PVs is based on previously
published data [12,13,14,27] and is represented as a continuum of nutrient entry, retention, release, and transfer. (1) Acidifying PVs contain fluid-
phase cargo, which is either free or retained by PV-resident receptors (blue ribbons). Released cargo travels further to the lumen of connecting ER
tubules. Some cargoes (green pentagon) can be excluded from further passage to the ER. (2) Uptake is mediated by fusion between the VSP-coated
PM and the PV membrane through PM-derived invaginations surrounded by clathrin arrays associated to AP2 complexes. This event corresponds to
the “kiss” phase in which formation of a channel allows exchange of fluid-phase material between the PV lumen and the extracellular space. Usable
nutrients may move freely or be bound by receptors lining the organelle lumen, whereas useless or harmful molecules may be released back in the
extracellular space during the “flush” phase. LDL receptor (GILRP) traffics in an AP2-dependent manner from the PM (1) to the PV membrane. (3)
PV–PM luminal continuity terminates and a new round of receptor-bound nutrient release mediated by intralumenal acidification ends with further
passage to connected ER. (4) The PV is now ready for another round of endocytosis and exchange with the extracellular environment and GILRP is
recycled back to the cell’s surface. ER, endoplasmic reticulum; GILRP, giardial putative low-density lipoprotein receptor; LDL, low-density
lipoprotein; PM, plasma membrane; PV, peripheral vacuole; TEM, transmission electron microscopy; VSP, variant surface protein.
https://doi.org/10.1371/journal.ppat.1007250.g001
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makes exchange of fluid-phase material bidirectional and likely compensates for the lack of
bona fide lysosomes as endpoints of endocytic transport. Endocytosis through PVs is likely the
main route of nutrient uptake into the Giardia cell, although there are isolated reports on
receptor-mediated uptake of lipid particles. The giardial putative low-density lipoprotein
(LDL) receptor (GILRP; purple ribbon in Fig 1C) in G. lamblia was shown to interact with
AP2 components [13], although its exact trafficking mechanism remains uncharacterized (Fig
1C). Short actin filaments were also shown to be involved in LDL uptake and were localized in
close proximity to PVs [14].
Fact 4: G. lamblia survives in the environment as infectious cysts
Completion of the life cycle by transmission of G. lamblia to a new host requires no vectors
and is based on the alternation of a vegetative stage, the trophozoite, and an environmentally
resistant infectious stage—the cyst. The cyst is the only stage of G. lamblia able to survive out-
side of the host and is responsible for the initiation of a new infectious cycle. Cyst development
may already begin in the small intestine of parasitized hosts when a variable fraction of prolif-
erating trophozoites initiates a cellular differentiation program called encystation [15]. Labora-
tory protocols for inducing encystation include lipid depletion and an increase in culturing
medium pH over a period of ca. 20–24 hours [16]. The assumption is that these conditions
mimic decreasing lipid availability and ascending pH gradients naturally present along the gas-
trointestinal tract. During encystation, flagellated pear-shaped binucleated trophozoites
undergo dramatic morphological and biochemical cellular remodeling, culminating in the for-
mation of nonflagellated oval quadrinucleated cysts, surrounded by a cyst wall (CW). The CW
is composed of a thick mesh of cyst wall proteins (CWPs) complexed to a unique sugar poly-
mer of β1,3-linked-N-acetylgalactosamine [17] and virtually shields the cyst’s interior from
any solvent. Deposition of the CW is a tightly-regulated event that occurs exclusively in encyst-
ing trophozoites and requires neogenesis of specialized secretory organelles called ESVs [18].
ESVs traffic, sort, and modify mainly CWPs from their initial site of deposition at the ER en
route to the parasite cell’s surface. Elimination of a single CWP by complete gene disruption
was shown to abolish CW formation altogether [19]. The exact in vivo stimuli for this process
are not yet well known, although recent studies on the dynamics of encystation in animal mod-
els point towards a link between high-density focal trophozoite populations in the proximal
small intestine and encystation [15]. These findings argue against the natural pH and lipid gra-
dients being the sole external triggers for differentiation. In turn, this raises the interesting pos-
sibility that trophozoites can sufficiently alter the local environment to generate conditions
favorable for triggering differentiation.
Cysts are then shed through host feces and were reported to remain viable for several
months in water at temperatures below 10 ˚C and several weeks at room temperature [20].
Based on experimental gerbil (Meriones ungulatus) infections, the minimal infectious dose is
less than 10 cysts [21]. Once viable cysts are ingested, passage through the stomach and physi-
cal stimuli (temperature, pH) initiate a cellular program termed excystation in which both
host and parasite proteases collaborate to degrade the CW, allowing the short-lived excyzoite
to escape and rapidly divide twice to give rise to four trophozoites [22]. In vitro (and most
likely in vivo) this process is completed within minutes [23].
Fact 5: Novel rational design-based vaccination strategies against
G. lamblia are yielding encouraging results
Currently, treatment of giardiasis in humans is based almost exclusively on administration of
antiprotozoals belonging to the family of 5-nitroimidazoles, whereas infected animals are
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007250 September 27, 2018 3 / 5
treated with benzimidazoles. A crude veterinary vaccine called GiardiaVax for nonchronically
infected dogs and cats was already licensed [24]. However, it does not inhibit trophozoite pro-
liferation and in many cases has to be combined with additional drug treatment. In recent
years, work done especially by the Lujan group at the Universidad Cato´lica de Co´rdoba in
Argentina has uncovered the potential for variant surface proteins (VSPs) as effective vaccina-
tion antigens in companion animals. The entire trophozoite surface is covered by a dense coat
of VSP anchored in the plasma membrane with a C-terminal hydrophobic transmembrane
anchor sequence. From a repertoire of over 200 homologous genes encoded in the parasite
genome, only one VSP is expressed on the surface of every single trophozoite at any given
moment. Antigenic switching and regulation of VSP expression were shown to occur by
RNAi-like mechanisms that could be perturbed to deregulate VSP production, leading to tro-
phozoites exposing the full VSP panel on their surface [25]. Oral vaccination trials on gerbils
showed that animals initially infected with deregulated cells expressing all of the VSPs encoded
in their genome are largely protected from challenge infections by Giardia clones that express
a unique VSP on their surface or by cysts obtained from infected individuals [25]. The same
vaccine was tested on cats and dogs, showing high efficiency in preventing new infections and
reducing chronic giardiasis in domestic animals both in experimental and natural infections
[26]. These data are based on the rational design of vaccination strategies underpinned by a
deep understanding of G. lamblia’s molecular and cell biology and hold great promise for erad-
ication of giardiasis in both animals and humans.
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